Wholesalers face shortage of Lamisil cream

Published: 2007-01-23 06:57:00

Updated: 2007-01-23 06:57:00

Wholesalers has been suffering from a shortage of Lamisil cream, co-marketed by Novartis Korea and Pacific Pharm, since its inventories were wholly returned to the manufacturer due to reduction of insurance price.

The shortage problem of Lamisil cream will unlikely be addressed soon as the man...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK